Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
pioglitazone hydrochloride, Quantity: 16.536 mg (Equivalent: pioglitazone, Qty 15 mg)
Arrotex Pharmaceuticals Pty Ltd
Pioglitazone hydrochloride
Tablet
Excipient Ingredients: carmellose calcium; hyprolose; magnesium stearate; lactose monohydrate
Oral
50 tablets, 7 tablets, 28 tablets, 98 tablets
(S4) Prescription Only Medicine
Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea
Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with '140' on one side and '15' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2011-10-26